Genome-Wide Screening Identifies Gene AKR1C1 Critical for Resistance to Pirarubicin in Bladder Cancer

SIMPLE SUMMARY: Bladder cancer is one of the most common malignant tumors in the urinary system. Pirarubicin (THP) perfusion therapy is an important treatment method for non-muscle-invasive bladder cancer. However, an increasing number of cases of recurrence or progression of bladder cancer caused b...

Descripción completa

Detalles Bibliográficos
Autores principales: Nie, Zhenyu, Gao, Yuanhui, Chen, Mei, Peng, Yanling, Guo, Na, Cao, Hui, Huang, Denggao, Gao, Xin, Zhang, Shufang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177075/
https://www.ncbi.nlm.nih.gov/pubmed/37173953
http://dx.doi.org/10.3390/cancers15092487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177075/
https://www.ncbi.nlm.nih.gov/pubmed/37173953
http://dx.doi.org/10.3390/cancers15092487

Ejemplares similares